Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10228258 | Biomaterials | 2013 | 11 Pages |
Abstract
Multiblock, high molecular weight, linear, backbone degradable HPMA copolymer-prostaglandin E1 (PGE1) conjugate has been synthesized by RAFT polymerization mediated by a new bifunctional chain transfer agent (CTA), which contains an enzymatically degradable oligopeptide sequence flanked by two dithiobenzoate groups, followed by postpolymerization aminolysis and thiol-ene chain extension. The multiblock conjugate contains Asp8 as the bone targeting moiety and enzymatically degradable bonds in the polymer backbone; in vivo degradation produces cleavage products that are below the renal threshold. Using an ovariectomized (OVX) rat model, the accumulation in bone and efficacy to promote bone formation was evaluated; low molecular weight conjugates served as control. The results indicated a higher accumulation in bone, greater enhancement of bone density, and higher plasma osteocalcin levels for the backbone degradable conjugate.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Huaizhong Pan, Monika Sima, Scott C. Miller, Pavla KopeÄková, Jiyuan Yang, JindÅich KopeÄek,